Asynchronous I/O, OAuth authentication, expanded SQL standards support, and new extension capabilities give developers faster performance, stronger security, and greater flexibility.
The FDA approved imlunestrant for treatment of certain adults with breast cancer who experience disease progression after at least one prior line of endocrine therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback